These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 9192249)

  • 21. In vitro and in vivo activities of novel 2-(thiazol-2-ylthio)-1beta-methylcarbapenems with potent activities against multiresistant gram-positive bacteria.
    Ueda Y; Sunagawa M
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2471-80. PubMed ID: 12878507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci.
    Hebeisen P; Heinze-Krauss I; Angehrn P; Hohl P; Page MG; Then RL
    Antimicrob Agents Chemother; 2001 Mar; 45(3):825-36. PubMed ID: 11181368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel dithiocarbamate carbapenems with anti-MRSA activity.
    Ohtake N; Imamura H; Jona H; Kiyonaga H; Shimizu A; Moriya M; Sato H; Nakano M; Ushijima R; Nakagawa S
    Bioorg Med Chem; 1998 Jul; 6(7):1089-101. PubMed ID: 9730246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical studies on vancomycin in the treatment of MRSA infection].
    Shimizu K; Orizu M; Kanno H; Kitamura S; Konishi T; Soma K; Nishitani H; Noguchi Y; Hasegawa S; Hasegawa H; Wada K
    Jpn J Antibiot; 1996 Aug; 49(8):782-99. PubMed ID: 9053533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
    Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of cefpirome combined with beta-lactamase inhibitors and affinity for the penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Piddock LJ; Traynor EA; Griggs DJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):364-71. PubMed ID: 1396760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
    Kobayashi Y
    J Infect Chemother; 2005 Oct; 11(5):259-61. PubMed ID: 16258825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of vancomycin resistance in MRSA strain Mu50].
    Hanaki H; Labischinski H; Sasaki K; Kuwahara-Arai K; Inaba Y; Hiramatsu K
    Jpn J Antibiot; 1998 Mar; 51(3):237-47. PubMed ID: 9597552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rapid and reliable detection of multiresistent Staphylococcus aureus (MRSA) by multiplex PCR].
    Domann E; Hossain H; Füssle R; Chakraborty T
    Dtsch Med Wochenschr; 2000 May; 125(20):613-8. PubMed ID: 11256043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases.
    Malouin F; Blais J; Chamberland S; Hoang M; Park C; Chan C; Mathias K; Hakem S; Dupree K; Liu E; Nguyen T; Dudley MN
    Antimicrob Agents Chemother; 2003 Feb; 47(2):658-64. PubMed ID: 12543674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of S-3578, a new broad-spectrum cephalosporin active against methicillin-resistant staphylococci.
    Fujimura T; Yamano Y; Yoshida I; Shimada J; Kuwahara S
    Antimicrob Agents Chemother; 2003 Mar; 47(3):923-31. PubMed ID: 12604523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T; Tateda E; Hiramatsu K; Yokota T
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of meropenem, against gram-positive bacteria.
    Kayser FH; Morenzoni G; Strässle A; Hadorn K
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.
    Hanaki H; Kuwahara-Arai K; Boyle-Vavra S; Daum RS; Labischinski H; Hiramatsu K
    J Antimicrob Chemother; 1998 Aug; 42(2):199-209. PubMed ID: 9738837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam.
    Matsuda K; Nakamura K; Adachi Y; Inoue M; Kawakami M
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2631-4. PubMed ID: 8592992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combination effect of vancomycin and cefpirome against methicillin-resistant Staphylococcus aureus in vitro--antimicrobial activities in postantibiotic phase].
    Hasegawa H; Kanai A; Otoguro K; Shimizu K
    Kansenshogaku Zasshi; 1996 Feb; 70(2):151-60. PubMed ID: 8851387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
    Chambers HF
    Antimicrob Agents Chemother; 1995 Feb; 39(2):462-6. PubMed ID: 7726516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis.
    Entenza JM; Hohl P; Heinze-Krauss I; Glauser MP; Moreillon P
    Antimicrob Agents Chemother; 2002 Jan; 46(1):171-7. PubMed ID: 11751129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
    Yanagihara K; Ohnishi Y; Morinaga Y; Nakamura S; Kurihara S; Seki M; Izumikawa K; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
    Int J Antimicrob Agents; 2008 Nov; 32(5):401-4. PubMed ID: 18715761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.